CellCept is a medicine used in adults and children from 1 year of age to prevent the body from rejecting a newly transplanted kidney, heart or liver. It is used together with ciclosporin and corticosteroids (other medicines to prevent the rejection of a transplanted organ). CellCept contains the active substance mycophenolate mofetil.
Therapeutic Indication
### Therapeutic indication CellCept is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult and paediatric (1 to 18 years of age) patients receiving allogeneic renal, cardiac or hepatic transplants.
Therapeutic Area (MeSH)
ATC Code
L04AA06
ATC Item
mycophenolic acid
Pharmacotherapeutic Group
Immunosuppressants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| mycophenolate mofetil | N/A | 吗替麦考酚酯 |
EMA Name
CellCept
Medicine Name
CellCept
Aliases
N/ANo risk management plan link.
